Trials / Withdrawn
WithdrawnNCT03249129
Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to detect the presence of autoantibodies and autoantigens in cerebrospinal fluid early (\<48 hours) following spinal cord trauma. The study also aims to define the central or peripheral origin of autoantibodies by looking for their simultaneous presence at the blood level and to evaluate the prognostic value of the presence of autoantibodies within the cerebrospinal fluid, as well as on the initial clinical severity than on the recovery potential.
Conditions
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2021-04-01
- Completion
- 2021-04-01
- First posted
- 2017-08-15
- Last updated
- 2019-12-05
Source: ClinicalTrials.gov record NCT03249129. Inclusion in this directory is not an endorsement.